Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lou Gehrig's Disease”

59 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 59 results

Not applicableUnknownNCT00420719
What this trial is testing

Motor-Point Stimulation for Conditioning the Diaphragm of Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis (ALS)
Synapse Biomedical 100
Testing effectiveness (Phase 2)WithdrawnNCT00561366
What this trial is testing

A Multicenter, Double-Blind Study to Investigate the Safety and Efficacy of Arimoclomol in Volunteers With ALS

Who this might be right for
Amyotrophic Lateral Sclerosis
CytRx
Not applicableStudy completedNCT00116558
What this trial is testing

Early Treatment of Amyotrophic Lateral Sclerosis (ALS) With Nutrition and Non-Invasive Positive Pressure Ventilation

Who this might be right for
Amyotrophic Lateral Sclerosis
Edward Kasaraskis 153
Not applicableLooking for participantsNCT01772602
What this trial is testing

The National Amyotrophic Lateral Sclerosis Registry

Who this might be right for
Amyotrophic Lateral Sclerosis
Centers for Disease Control and Prevention 30,000
Early research (Phase 1)Study completedNCT03520517
What this trial is testing

Open-label Study to Evaluate Safety, Tolerability and PK of BHV-0223 in ALS

Who this might be right for
Amyotrophic Lateral SclerosisALSLou Gehrig Disease+3 more
Biohaven Pharmaceuticals, Inc. 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04055623
What this trial is testing

T-regulatory Cells in ALS

Who this might be right for
ALS (Amyotrophic Lateral Sclerosis)
The Methodist Hospital Research Institute 12
Testing effectiveness (Phase 2)Study completedNCT02450552
What this trial is testing

Clinical Trial of Ezogabine (Retigabine) in ALS Subjects

Who this might be right for
Amyotrophic Lateral Sclerosis
Brian Wainger 65
Large-scale testing (Phase 3)Study completedNCT05842941
What this trial is testing

HEALEY ALS Platform Trial - Regimen G DNL343

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 249
Large-scale testing (Phase 3)Study completedNCT05740813
What this trial is testing

HEALEY ALS Platform Trial - Regimen F ABBV-CLS-7262

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 310
Early research (Phase 1)Temporarily pausedNCT01082653
What this trial is testing

Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis

Who this might be right for
Amyotrophic Lateral Sclerosis
TCA Cellular Therapy 6
Not applicableLooking for participantsNCT05067179
What this trial is testing

Analysis of Human ALS Tissues and Registry of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
University of Illinois at Chicago 40
Large-scale testing (Phase 3)Looking for participantsNCT03127267
What this trial is testing

Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients

Who this might be right for
Amyotrophic Lateral Sclerosis
AB Science 495
Large-scale testing (Phase 3)Looking for participantsNCT04297683
What this trial is testing

HEALEY ALS Platform Trial - Master Protocol

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 1,500
Large-scale testing (Phase 3)Study completedNCT05136885
What this trial is testing

HEALEY ALS Platform Trial - Regimen E SLS-005 - Trehalose

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 161
Not applicableStudy completedNCT03868345
What this trial is testing

Speech Analysis in ALS Patients

Who this might be right for
ALSAmyotrophic Lateral SclerosisLou Gehrig Disease
Barrow Neurological Institute 26
Testing effectiveness (Phase 2)Ended earlyNCT04326283
What this trial is testing

Trial of Safety, Tolerability and Efficacy of Trametinib (SNR1611) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral Sclerosis
Genuv Inc. 23
Testing effectiveness (Phase 2)Study completedNCT00956488
What this trial is testing

Supported Treadmill Ambulation Training (STAT) for Patients Diagnosed With Amyotrophic Lateral Aclerosis

Who this might be right for
Amyotrophic Lateral SclerosisMotor Neuron DiseaseLou Gehrig's Disease
Wake Forest University Health Sciences 9
Large-scale testing (Phase 3)Study completedNCT04436497
What this trial is testing

HEALEY ALS Platform Trial - Regimen A Zilucoplan

Who this might be right for
Amyotrophic Lateral Sclerosis
Merit E. Cudkowicz, MD 162
Not applicableLooking for participantsNCT06649955
What this trial is testing

Controlling Amyotrophic Lateral Sclerosis Motor Neuron Excitability Study

Who this might be right for
ALS - Amyotrophic Lateral Sclerosis
PathMaker Neurosystems Inc. 15
Large-scale testing (Phase 3)Study completedNCT00125203
What this trial is testing

Study of Myobloc in the Treatment of Sialorrhea (Drooling) in Patients With Amyotrophic Lateral Sclerosis (ALS)

Who this might be right for
Amyotrophic Lateral SclerosisSialorrhea
The University of Texas Health Science Center at San Antonio 20
Load More Results